RecruitingNot ApplicableNCT03494946

Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer

A Randomized Clinical Trial Comparing Overall Survival in Selected Patients With ColoRectal Carcinoma Treated by Liver Transplantation or Chemotherapy


Sponsor

Oslo University Hospital

Enrollment

30 participants

Start Date

Dec 5, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

The trial is a randomized control trial. Patients are randomized between Ltx and other treatment that may include further chemotherapy, TACE, SIRT or other available treatment options. The patients will be randomized 1:1 to Ltx and chemotherapy/other treatment options.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether a liver transplant might help people with colorectal cancer that has spread to the liver — a situation where standard surgery to remove the cancer is no longer possible — and comparing that approach to ongoing chemotherapy. **You may be eligible if...** - You have been diagnosed with colorectal cancer (cancer of the colon or rectum) that has spread to the liver - The liver tumors cannot be surgically removed - Scans show the cancer has not spread beyond the liver (small lung spots may be okay) - You are in reasonably good overall health and can handle daily activities - Your blood counts, liver function, and kidney function are within acceptable ranges - Your cancer has grown or you could not tolerate first-line chemotherapy **You may NOT be eligible if...** - You have lost more than 10% of your body weight in the last 6 months - Your BMI is over 30 - You have had surgery for cancer recurrence or spread to other organs within the last 1–2 years - The cancer has previously spread to your bones, brain, or lymph nodes outside the liver - You have had breast cancer or melanoma before - Your primary colon/rectal tumor has not been fully removed - You have a liver tumor larger than 10 cm - You have three specific high-risk factors at the time of enrollment (very high CEA blood marker, cancer diagnosed less than 2 years ago, and largest liver tumor over 5.5 cm) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELiver transplantation
DRUGChemotherapy

May include chemotherapy, TACE, SIRT or other available treatment options.


Locations(1)

Oslo University Hospital

Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03494946


Related Trials